US 8987426
Immunotoxin fusion proteins and means for expression thereof
granted A61KA61K47/6829A61K47/6849
Quick answer
US patent 8987426 (Immunotoxin fusion proteins and means for expression thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K47/6829, A61K47/6849